Want to join the conversation?
Global biotechnology company $VRTX said the European Commission has approved the expanded use of the KALYDECO (ivacaftor) drug for the treatment of cystic fibrosis, a genetic disorder that affects the lungs and other organs in children aged 2 to 5 having one of nine gating mutations and in adults aged 18 and older having R117H mutation.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.